Outcomes of MF Patients Exposure to Ruxolitinib During Transplantation

Clinical trial NCT04526223 · UNKNOWN

Trial details

NCT number: NCT04526223
Sponsor: xuna
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Time of Hematopoietic Reconstruction

Start date: 2017-04-20
Primary completion: 2022-12-20
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.